Former FDA Head Proposes CBD Regulation Plan
Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb described a potential regulatory process for CBD on Friday, laying out steps the agency could take while final rules are developed. While Gottlieb urged caution against the use of cannabidiol products and argued that claims about the compound’s medical potential are largely unsubstantiated, he said there are certain measures FDA can implement to ensure that such preparations meet basic safety standards. The former commissioner linked to an article challenging claims about CBD and stated that the “hype has outpaced science” and that “there are risks.” CBD hype has outpaced science. And there are risks. But with use widespread, the question is whether FDA can help oversee quality, purity, potency and help prevent third rate purveyors from flooding market with shoddy products outside regulatory purview https://t.co/PErCX9ZjuJ — Scott Gottlieb, MD (@ScottGottliebMD) November 8, 2019 “But with use widespread, the question is whether FDA can help oversee quality, purity, potency and help prevent third rate purveyors from flooding market with shoddy products outside regulatory purview,” he wrote on Twitter. To start, Gottlieb recommended targeting regulations at CBD supplements, which are not currently allowed to be marketed because FDA has yet to issue rules—but…
Excerpt only …
READ MORE BELOW
Source : MJ moment
Link to original : Former FDA Head Proposes CBD Regulation Plan
reposted by Cannabis News World
You must log in to post a comment.